Menu Philippe 4

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on 2026-04-27. The reported weighted-average price was $4.82 per share (range $4.75–$4.89), for total proceeds of approximately $24,089. This was a sale (not a purchase); the filing notes the sale was made under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-04-27; filing date: 2026-04-28 (filed within the Form 4 reporting window).
• Price: weighted average $4.82; reported trade prices ranged from $4.75 to $4.89.
• Shares sold: 5,000; proceeds ≈ $24,089.
• Shares owned after transaction: not disclosed in the information provided.
• Footnotes: F1 — transaction made pursuant to a duly adopted Rule 10b5-1(c) plan; F2 — the $4.82 is a weighted average and the filer can provide a per-price breakdown on request.
• Timeliness: filing appears timely (next business day).

Context
Sales made under 10b5-1 plans are pre-planned and commonly used to avoid trading-window issues; they are often routine and do not necessarily reflect new views about the company. The dollar amount here is modest (~$24K), so this single sale is unlikely to materially affect ownership or signal major insider conviction. Retail investors should weigh insider trades alongside other fundamentals and news.